Guerieye Mox Gel contains Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of bacterial eye infections such as bacterial conjunctivitis and keratitis. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, thereby leading to bacterial cell death. Guerieye Mox Gel is formulated for topical ophthalmic use, ensuring targeted delivery to the site of infection with minimal systemic absorption. It is effective against a wide range of Gram-positive and Gram-negative pathogens, including strains resistant to other antibiotics. The gel base enhances ocular retention time, improving drug bioavailability and therapeutic efficacy. Guerieye Mox Gel should be used as directed by a healthcare professional, typically instilled into the affected eye(s) several times daily for the prescribed duration. Patients should avoid contamination of the applicator tip and discontinue use if hypersensitivity or adverse reactions occur. This medication is contraindicated in individuals with known hypersensitivity to moxifloxacin or other quinolones. Guerieye Mox Gel offers a potent and convenient option for managing bacterial ocular infections, promoting rapid resolution of symptoms and preventing complications.